Slavin, A J <br/><br/>
Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes.  [electronic resource] 

 -  International immunology  Jun 2001 
 - 825-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0953-8178 
<br/><br/><label>Standard No.: </label>10.1093/intimm/13.6.825  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Administration, Intranasal<br/>Administration, Oral<br/>Animals<br/>Cell Division--immunology<br/>Cells, Cultured<br/>Cytokines--antagonists & inhibitors<br/>Diabetes Mellitus, Experimental--immunology<br/>Encephalomyelitis, Autoimmune, Experimental--immunology<br/>Female<br/>Immune Tolerance<br/>Immunity, Mucosal<br/>Immunosuppressive Agents--administration & dosage<br/>Injections, Subcutaneous<br/>Interleukin-10--administration & dosage<br/>Lymph Nodes--cytology<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, Inbred Strains<br/>Mouth Mucosa--immunology<br/>Myelin Basic Protein--administration & dosage<br/>Myelin Proteins<br/>Myelin-Associated Glycoprotein--administration & dosage<br/>Myelin-Oligodendrocyte Glycoprotein<br/>Nasal Mucosa--immunology<br/>Recurrence